乙肝病毒cccDNA的分子合成机制以及药物干预

发布时间 : 2013/06/21点击量:
报告题目:乙肝病毒cccDNA的分子合成机制以及药物干预

报告时间:2013年6月21日上午9:00

报告地点:金沙8888js官方一楼中厅

报 告 人:Haitao Guo, Ph.D
(Associate Professor, Department of Microbiology and Immunology, Drexel University College
of Medicine)

报告人简介:
Haitao Guo
Positions and Employment
2002.1 - 2004.10 Post-Doctoral Fellow, Fox Chase Cancer Center, Philadelphia, PA
2004.11- 2008.9 Instructor, Drexel University College of Medicine. Doylestown, PA
2008.10- 2011.8 Assistant Professor, Drexel University College of Medicine. Doylestown, PA
2011.9 - date Associate Professor, Department of Microbiology and Immunology,
Drexel University College of Medicine. Doylestown, PA
Education
Post Doc 2002-2004 Fox Chase Cancer Center, Philadelphia, PA
PHD; 1996-2001; Wuhan University
BS; 1992-1996; Wuhan University
Research Areas
Ourresearch centers on the molecular biology of HBV replication and morphogenesis, innate
immunity control of HBVreplication, as well as antiviral drug screening and development.
Three major ongoing projects are briefly described as below:
1. Molecular pathway of HBV covalently closed circular (ccc) DNA formation.
2. Screening and development of small molecule compounds that inhibit HBV cccDNA
formation
3. Innate control of HBV infection

主讲人 时间
地址

返回顶端

Baidu
sogou